New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

Gina Domanig is the Managing Partner of Emerald Technology Ventures. In 2000 she founded the business as the first ...

About Michael McClintock, P.ENG. Michael specializes in strategically guiding and managing capital, focusing on capital efficiency and value creation. His expertise lies in steering companies towards ...

A biomaterial that can mimic certain behaviors within biological tissues could advance regenerative medicine, disease modeling, soft robotics and more, according to researchers.

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

The race is on to build a new generation of healthcare software to replace legacy hospital systems that in some cases may not have been updated in ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

Belite Bio is a biotech firm specializing in innovative therapies for retinal degenerative eye diseases with high unmet needs ...

For decades, the US healthcare system has struggled to address the diet-related chronic illnesses affecting nearly half of ...

Plus: A new non-opioid painkiller, the wave of lawsuits against Trump EOs, a key vote for RFK Jr., a big radiopharma deal and ...